MIRONID LIMITED

SC476430
Active Glasgow

Research and experimental development on biotechnology

16 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
M

MIRONID LIMITED

SC476430

Research and experimental development on biotechnology

Founded 29 Apr 2014 Active Glasgow, Scotland 16 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 17 Jul 2025 Next due 30 Nov 2026 5 months remaining
Confirmation Submitted 25 Sept 2025 Next due 4 Oct 2026 3 months remaining
Net assets £-12M £7M 2024 year on year
Total assets £4M £6M 2024 year on year
Total Liabilities £16M £1M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Arbuthnott Building (Hamnett Wing) 161 Cathedral Street Glasgow G4 0RE Scotland

Website

www.example.com

Full company profile for MIRONID LIMITED (SC476430), an active life sciences and medical technology company based in Glasgow, Scotland. Incorporated 29 Apr 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Mar → 28 Feb 2025
Type small
Next accounts 28 Feb 2026
Due by 30 Nov 2026 5 months remaining

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£2.30M

Decreased by £5.44M (-70%)

Net Assets

-£12.12M

Decreased by £7.00M (-137%)

Total Liabilities

£16.14M

Increased by £1.27M (+9%)

Turnover

N/A

Employees

16

Increased by 1 (+7%)

Debt Ratio

402%

Increased by 249 (+163%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
28 Feb Year End
2024
29 Feb Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 1

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 4Jun 2016Series A
Investor 6Jun 2016Series A
Investor 8Jun 2016Series A

Share Capital

Share Capital

Share allotments and capital structure

18 Allotments 2,186,380 Shares £53.40m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
19 May 2026397,511£11.50m£28.93
31 Mar 202634,564£1000k£28.93
31 Mar 2026918,937£19.94m£21.698
21 Aug 202316,726£1.673£0
31 Mar 2023353,368£8.18m£23.144

Officers

Officers

2 active 1 resigned
Status
Daniela Andreia Dos Santos CoutoDirectorPortugueseNetherlands4121 Oct 2022Active
Elaine Verne JonesDirectorAmericanUnited States7128 Aug 2019Active

Shareholders

Shareholders (21)

Epidarex Capital Ii, Lp
38.0%
Scottish Enterprise Glasgow
22.0%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Epidarex Capital Ii, L.p.

Ceased 18 Dec 2019

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 May 2026CapitalAllotment of shares (GBP 227.9591) on 20 May 2026
22 Apr 2026CapitalAllotment of shares (GBP 188.208) on 1 Apr 2026
13 Apr 2026IncorporationMemorandum Articles
10 Apr 2026ResolutionResolutions
10 Apr 2026ResolutionResolutions
29 May 2026 Capital

Allotment of shares (GBP 227.9591) on 20 May 2026

22 Apr 2026 Capital

Allotment of shares (GBP 188.208) on 1 Apr 2026

13 Apr 2026 Incorporation

Memorandum Articles

10 Apr 2026 Resolution

Resolutions

10 Apr 2026 Resolution

Resolutions

Recent Activity

Latest Activity

Allotment of shares (GBP 227.9591) on 20 May 2026

2 weeks ago on 29 May 2026

Allotment of shares (GBP 188.208) on 1 Apr 2026

1 months ago on 22 Apr 2026

Memorandum Articles

2 months ago on 13 Apr 2026

Resolutions

2 months ago on 10 Apr 2026

Resolutions

2 months ago on 10 Apr 2026